Ann Lab Med.  2025 Mar;45(2):218-222. 10.3343/alm.2024.0118.

Performance Evaluation of the LabGenius C-CT/NG-BMX Assay for Chlamydia trachomatis and Neisseria gonorrhoeae Detection

• Lim YK
• Kweon OJ
• Park AJ
• Kim H
• Yoon S
• Kim TH
• Lee MK

• KMID: 2565653
• DOI: http://doi.org/10.3343/alm.2024.0118

Abstract

The LabGenius C-CT/NG-BMX assay (LabGenius CT/NG; BIOMEDUX, Gyeonggi, Republic of Korea) is a recently developed real-time PCR assay that can simultaneously detect the sexually transmitted pathogens Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in genitourinary specimens. We evaluated the analytical performance of this assay in comparison with BD MAX CT/GC/TV (Becton Dickinson, Franklin Lakes, NJ, USA). The results of both assays were in nearly perfect agreement for the detection of CT and NG. LabGenius CT/NG demonstrated acceptable analytical performance, comparable with that of another commercially available kit, and provides a cost-effective option for detecting sexually transmitted pathogens in routine and follow-up testing.

Keyword

Chlamydia trachomatis; Diagnostic tests; Evaluation; Neisseria gonorrhoeae; PCR; Sexually transmitted pathogens

Figure

• 

  Fig. 1 Binomial logistic regression analysis of the percent positive results of LabGenius CT/NG according to (A) Chlamydia trachomatis (CT) and (B) Neisseria gonorrhoeae (NG) DNA concentrations.

Reference

References

1. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. 2001; Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol. 39:1751–6. DOI: 10.1128/JCM.39.5.1751-1756.2001. PMID: 11325985. PMCID: PMC88020.

2. Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, et al. 2022; Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis. 22:541–51. DOI: 10.1016/S1473-3099(21)00448-5. PMID: 34942091.

3. WHO. Fact Sheets - gonorrhoea (Neisseria gonorrhoeae infection). https://www.who.int/news-room/fact-sheets/detail/gonorrhoea-(neisseria-gonorrhoeae-infection). Updated on Jul 2024.

4. WHO. Fact Sheets - Chlamydia. https://www.who.int/news-room/fact-sheets/detail/chlamydia. Updated on July 2023.

5. Gradison M. 2012; Pelvic inflammatory disease. Am Fam Physician. 85:791–6. DOI: 10.1007/springerreference_44420.

6. Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield HH, et al. 2011; The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 38:503–9. DOI: 10.1097/OLQ.0b013e318206c288. PMID: 22256336. PMCID: PMC3408314.

7. CLSI. 2023. Evaluation of qualitative, binary output examination performance. 3rd ed. Clinical and Laboratory Standards Institute;Wayne, PA: EP12.

8. CLSI. 2014. Evaluation of precision of quantitative measurement procedures; approved guideline. 3rd ed. Clinical and Laboratory Standards Institute;Wayne, PA: EP05-A3.

9. Landis JR, Koch GG. 1977; The measurement of observer agreement for categorical data. Biometrics. 33:159–74. DOI: 10.2307/2529310. PMID: 843571.

10. Park S-H, Hwang K-A, Ahn JH, Nam J-H. 2020; Evaluation of multiplex polymerase chain reaction assay for the simultaneous detection of sexually transmitted infections using swab specimen. J Bacteriol Virol. 50:44–54. DOI: 10.4167/jbv.2020.50.1.044.

11. Wihlfahrt K, Günther V, Mendling W, Westermann A, Willer D, Gitas G, et al. 2023; Sexually transmitted diseases-an update and overview of current research. Diagnostics (Basel). 13:1656. DOI: 10.3390/diagnostics13091656. PMID: 37175047. PMCID: PMC10178083. PMID: af085110066646d8abc15d8b67118fe0.

12. Pereyre S, Caméléna F, Hénin N, Berçot B, Bébéar C. 2022; Clinical performance of four multiplex real-time PCR kits detecting urogenital and sexually transmitted pathogens. Clin Microbiol Infect. 28:733.e7–733.e13. DOI: 10.1016/j.cmi.2021.09.028. PMID: 34610459.

13. Dakhave M, Gadekar S, Malekar A, Wankhede G. 2023; 'CoviSwift^TM': a point-of-care RT-PCR device for SARS-CoV-2 and its variant detection. J Virol Methods. 315:114714. DOI: 10.1016/j.jviromet.2023.114714. PMID: 36934897. PMCID: PMC10023201.